To cite this paper use one of the standards below:
Based on new cases of resistance of Plasmodium falciparum to antimalarial drugs, the need for research of new antimalarial drug candidates is urgent1. Molecular docking studies on a series of fluoroamodiaquine (FAQ) analogues were previously conducted by our research group and a synthetic route was planned2. Here, we propose the synthesis of new FAQ analogues using the previously described methodology (Figure 1).
The compounds were tested in vitro against a sensitive and resistant chloroquine strains of Plasmodium falciparum (NF54 and K1, respectively)3. Compounds 7a and 7b presented the lowest IC50 values, highlighting their results against the resistant strain K1, which were lowest than chloroquine (0,015 and 0,057μM). These compounds also demonstrated the best cytotoxicity profile. The β-hematin assay was also performed presenting inhibition profile similar to amodiaquine and chloroquine. The molecular docking is in progress. These results indicate that FAQ analogues are promising molecules for the treatment of malaria.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper